Physician
Baig, Imran
Baig, Imran was paid $8.97M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 22% of everything it billed.
33Billing provider infoBAIG, IMRAN
HOUSTON, TX 77015
HOUSTON, TX 77015
33aNPI1679567838assigned 09/02/2005
33bProvider typeInternal Medicine Physician
28Total paid$8.97M
24GClaims289,893
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Texas
Rank by total paid#6 of 1,028
Median peer was paid$10K
This provider vs. median862×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,172 | $42K | |
| 2019 | 802 | $24K | |
| 2020 | 9,170 | $231K | |
| 2021 | 60,695 | $1.42M | |
| 2022 | 70,625 | $1.69M | |
| 2023 | 85,168 | $3.09M | |
| 2024incomplete | 62,261 | $2.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 22% | 7,432 | 1,034 | $1.94M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 37,220 | 33,547 | $1.46M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.9% | 14,517 | 13,494 | $795K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.5% | 6,983 | 6,888 | $673K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.1% | 7,131 | 7,024 | $633K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.8% | 7,234 | 7,116 | $606K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 6.0% | 1,576 | 1,464 | $538K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.9% | 39,598 | 18,717 | $443K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.8% | 5,471 | 5,312 | $432K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 16,424 | 15,598 | $234K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 3,970 | 3,842 | $209K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 6,087 | 5,324 | $156K |
76 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 5,888 | $152K |
| S8301 | Infection control supplies, not otherwise specified | 1.2% | 14,427 | $105K |
| 95180 | <1% | 180 | $78K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 873 | $73K |
| 99383 | <1% | 730 | $71K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,038 | $65K |
| 99381 | <1% | 847 | $65K | |
| 99384 | <1% | 452 | $48K | |
| 90461 | <1% | 8,784 | $34K | |
| 99382 | <1% | 328 | $33K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,720 | $19K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,404 | $18K |
| 87807 | <1% | 1,611 | $17K | |
| 95117 | <1% | 1,954 | $16K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 326 | $15K |
| 97802 | <1% | 13,767 | $10K | |
| 95115 | <1% | 988 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 541 | $6K |
| 96160 | <1% | 3,935 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 41 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 238 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 251 | $3K |
| 81002 | <1% | 1,041 | $3K | |
| 94010 | <1% | 77 | $2K | |
| 36410 | <1% | 105 | $881.88 | |
| 90700 | <1% | 1,292 | $771.53 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 96 | $488.39 |
| 97803 | <1% | 13 | $157.50 | |
| 90473 | <1% | 48 | $78.36 | |
| 97169 | <1% | 918 | $76.74 | |
| 99000 | <1% | 6,094 | $56.36 | |
| 90658 | <1% | 286 | $40.66 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 307 | $30.54 |
| 90686 | <1% | 5,035 | $20.43 | |
| 92551 | <1% | 3,983 | $15.08 | |
| 94760 | <1% | 250 | $11.17 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 5,995 | $4.52 |
| 90677 | <1% | 1,599 | $2.35 | |
| 90651 | <1% | 1,753 | $0.25 | |
| 90734 | <1% | 2,791 | $0.24 | |
| 90620 | <1% | 345 | $0.23 | |
| 99001 | <1% | 17 | $0.16 | |
| 90715 | <1% | 1,486 | $0.06 | |
| 84030 | <1% | 80 | $0.02 | |
| 90670 | <1% | 3,355 | $0.01 | |
| 90633 | <1% | 2,928 | $0.01 | |
| 90723 | <1% | 2,380 | $0.01 | |
| 99177 | 0% | 2,033 | $0.00 | |
| 99173 | 0% | 3,907 | $0.00 | |
| 90710 | 0% | 2,435 | $0.00 | |
| 3725F | 0% | 820 | $0.00 | |
| 90707 | 0% | 166 | $0.00 | |
| 90671 | 0% | 60 | $0.00 | |
| 0486T | 0% | 23 | $0.00 | |
| 90681 | 0% | 12 | $0.00 | |
| 90685 | 0% | 52 | $0.00 | |
| 90696 | 0% | 1,389 | $0.00 | |
| 90647 | 0% | 3,673 | $0.00 | |
| 36416 | 0% | 2,667 | $0.00 | |
| 90698 | 0% | 946 | $0.00 | |
| 90680 | 0% | 3,102 | $0.00 | |
| 2000F | 0% | 2,600 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 217 | $0.00 |
| 90716 | 0% | 140 | $0.00 | |
| 96127 | 0% | 3,773 | $0.00 | |
| 2010F | 0% | 462 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,563 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 27 | $0.00 |
| V5008 | Hearing screening | 0% | 576 | $0.00 |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | 0% | 270 | $0.00 |
| 1036F | 0% | 87 | $0.00 | |
| 99174 | 0% | 509 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 71 | $0.00 |
| 90697 | 0% | 15 | $0.00 | |
| 90747 | 0% | 12 | $0.00 | |
| 90744 | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.